TP53 and acute myeloid leukemia: To model our clinical results (obtained in PML-RARA-negative AML patients), we employed the U937 cell line model representing TP53-mutated AML (constituting a substantial proportion of elderly AML patients) and MOLM-13 representing AML with functional p53.